Cancer Gateway

Welcome to BioMed Central's Cancer Gateway, highlighting the latest articles we have published in this field. Content is continually updated, so please bookmark this page and ensure you check it regularly.

Articles

There has been an error retrieving the data. Please try again.
  • Identifying gaps in breast cancer research

    Current knowledge 'gaps' in the understanding of breast cancer are examined, and research should focus on these to improve future clinical care.

    Breast Cancer Research 2013, 15:R92
  • Signaling cell fate in cancer cells

    In this important study to help understand the bimodal function of PKA, Hedrick et al present their findings regarding differential activation of PKA and the role of AKAPs in cell survival decisions.

    Journal of Molecular Signaling 2013, 8:10
  • Image attributed to: Mutation in DNA strand_from iStockPhoto

    What can cancer mutation signatures tell us?

    Reuben Harris discusses how mutational signatures could be diagnostic, prognostic, and therapeutic biomarkers, highlighting a recent study that found several signatures across different cancer types.

    Genome Medicine 2013, 5:87
  • Image attributed to: cell

    p53-induced lincRNA

    A novel lincRNA, PINT, connects p53 activation with epigenetic silencing by PRC2 and is identified as a candidate tumor suppressor

    Genome Biology 2013, 14:R104
  • Is diet protective in traumatic brain injury?

    Kitagishi and Matsuda review the signaling pathways involved in traumatic encephalopathy and the effect of dietary supplements on these mechanisms, especially the role of the PI3K/AKT/PTEN pathway in neuroprotection and therapy.

    Alzheimer's Research & Therapy 2013, 5:42

AuthorMapper

Authors of BioMed Central cancer-related articles, by location

Powered by AuthorMapper.com

News and events

Biomarker Research, a new journal encompassing all aspects biomarker investigation, has now launched. Visit the journal website to read the first articles, including a review by co-Editor-in-Chief Delong Liu on the clinical applications of JAK inhibitors, and sign up for article alerts.

ez-reprint

Author profile

Wei Zhang

Director, Cancer Genomics Core Lab, University of Texas